Non-pedunculated subcentimetric colorectal polyp (adenoma or sessile serrated adenoma/polyp)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients who has subcentimetric colorectal polyp 2.Patients taking anticoagulant 3.Patients agreed to participate to the study after informed consent. 4.PS, 0,1 5.Plt, normal range. Cre, less than2.0mg/dl PT % more than 70% (In case of patients taking warfarin, the range of PT-INR should be within 1.5-3.0)
Exclusion criteria
Exclusion criteria: 1.Previous enrollment to this study. 2.Inflammatory bowel disease, polyposis patient. 3.Polyps larger than 10mm, lesions suspicious for cancer, pedunculate type polyp, or depressed type polyp. 4.Patients taking steroid, anti platelet, multiple anticoaglants. 5.Non-correctable coagulopathy 6.Pregnancy or lactating 7.Psychiatric disorder 8.Active infection 9.Non-correctable hypertention 10.Chronic respiratory failure 11.Undergo artificial dialysis 12.Inappropriate to participate to the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Procedure related immediate and delayed bleeding rate. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hematochezia rate (not requiring endoscopic hemostasis), Immediate bleeding rate, Mean procedure time, Mean hospitalization (for subcentimetric polyp, for all polyps), Number of total colonoscopy for clean colon, Adverse event. | — |
Countries
Japan
Contacts
Osaka International Cancer Institute Gastrointesitnal Oncology